September 20/22 2018 – Hotel Kempinski, Berchtesgaden
Thursday, September 20th
| Dinner at a typical German “Almhütte” | |||
| 18:00 | Start of the hiking trip | ||
| 18:30 | Bus departure to the “Almhütte” | ||
Friday, September 21st
| Welcome | ||||||
| 09:00 | 09:10 | Welcome and Introduction | ||||
| 09:10 | 11:00 | Introduction round | ||||
| 11:00 – 11:30 | Coffee Break | |||||
| Session I: Composition and Brain | ||||||
| 11:30 | 12:00 | Fecal microbiota transplantation and “dark matters” of the gut | Siew C. Ng, Hong Kong Zuo Tao |
|||
| 12:00 | 12:30 | Intenstinal microbiota and barrier: A trigger of stress and aging? | Ina Bergheim, Wien Anja Baumann |
|||
| 12:30 | 12:55 | The Tryptophan paradigm – microbiome-targeted therapy for many diseases | Stefan Schreiber, Kiel | |||
| 12:55 | 13:25 | The Kynuernine Pathway as a systematic link | Markus Schwarz, Munich, Jana Sonner |
|||
| 13:25 – 14:25 | Buffet Lunch | |||||
| Session II: Therapy shaping the microbiome | ||||||
| 14:25 | 14:55 | Of probiotics in the gynaecological oncology | Jalid Sehouli, Berlin Adolf Heschl |
|||
| 14:55 | 15:20 | Probiotics in clinical application | Vanessa Stadlbauer-Köllner, Graz Angela Horvath |
|||
| 15:20 | 15:45 | Pathway-based approach to classify unannotated gut bacteria associated with insulin sensitivity | Susanne Brix Pedersen, Kopenhagen | |||
| 15:45 | 16:15 | Loss of Colonization Resistance within the Gastrointestinal Microbiome During Critical Illness | Daniel Freedberg, New York | |||
| 16:15– 16:45 | Coffee Break | |||||
| Session III: Family Health | ||||||
| 16:45 | 17:15 | The host-microbiome interplay in men and great apes | Andre Franke, Kiel Malte Rühlemann |
|||
| 17:15 | 17:45 | Importance of the genital microbiome in HIV transmission | Rupert Kaul, Québec Lukas Grumet |
|||
| 17:45 | 18:15 | Hormones and the gut | Barbara Obermayer-Pietsch, Graz Angelo Ascani |
|||
| 18:15 | 18:45 | The human archaeome | Christine Moissl-Eichinger, Graz Alexander Mahnert |
|||
| 19:30 | Dinner at Le Ciel | |||||
Saturday, September 22nd
| Session IV: Composition of human microbiomes | |||
| 09:00 | 09:30 | The gut microbiota – critical modifier of immune-modulatory therapies | Philip Rosenstiel, Kiel Corinna Bang |
| 09:30 | 10:00 | Population studies of gut microbiome: effect of medication, diet and other factors | Alexandra Zhernakova, Groningen Alexander Kurilshikov |
| 10:00 | 10:30 | Host-gut microbiota interactions and metabolic traits in mice and human | Elin Org, Tartu Kreete Lüll |
| 10:30 | 10:55 | Role of the Microbiome in Barrett’s Esophagus | Julian Abrams, New York |
| 10:55– 11:25 | Coffee Break | ||
| Session V: Nutrition and Microbiome | |||
| 11:25 | 11:50 | Modulating the gut microbiota improves liver disease | Bernd Schnabl, San Diego |
| 11:50 | 12:15 | Multi-omics approaches for analysis of the gut microbiota | Karsten Kristiansen, Kopenhagen |
| 12:15 | 12:40 | Gut microbiome in host health and diseases: some perspectives | Jun Wang, Beijing |
| 12:40 | 13:30 | Final discussion/closing remarks | |
| 13:30 | Buffet Lunch | ||